Small CDMO
Market Cap
₹2,679 ₹2,679 Cr.
P/E
165.81
PEG
3.68
PEG = P/E ÷ 5yr Forward EPS CAGR
5yr Forward EPS CAGR Thesis - Base Case

- The thesis comes live as India utilization and customer order conversion improve, French losses narrow and late-phase work reaches commercial supply.- The bull path depends on above-plan India conversion and timely ADC capacity expansion, while the bear path reflects slow conversion, underused capacity and a loss-making French facility.

Key Ratios

Debt to Equity
Debt to Equity
0.36
Div Yield (%)
Div Yield (%)
-
Individual < 2 lac
Individual < 2 lac
14.98 %
Institutions
Institutions
8.91 %
Market cap
Market cap
2,679 Cr
No. of Shareholders
No. of Shareholders
49,430
OPM (%)
OPM (%)
16.72 %
PE
PE
165
Prom Holding
Prom Holding
59.32 %
ROCE (%)
ROCE (%)
2.44
ROE (%)
ROE (%)
0.06
Sales
Sales
2,901 Cr
  • Dishman Carbogen Amc
  • Zenotech Labs.
  • Jeevan Scientific
  • TJI Pharma - Small Cap
Last updated on
      Price Range

      See where the stock is trading versus its 52-week high and low.

      Low
      129
      52W Range
      High
      322
      Timeline

      Key company specific updates.

      Custom financial statement

      Edit rows

      Forensics

      7 Yes

      Positive for this company

      1 Neutral

      Neutral for this company

      9 No

      Negative for this company

      0 No Data

      Insufficient data to analyse

      Revenue mix

      Product Wise Break-Up

      Segment Break-Up - Marketable Molecules

      Location Wise Break-Up - Contract Research & Contract Manufacturing (CRAMS)

      Location Wise Break-Up

      Therapeutic Area Break-Up

      Operating Profit Break-Up

      Operational Metrics

        Select a Metric
        • US DMF Filings (.)
        • Total reactor capacity (kL)
        • R&D as a % of Total Sales (%)

        Peer Comparison

        Corporate Actions

        Consolidated
        DATE
        DETAILS
        Show More
        Show Less
        Show More
        Show Less

        FAQs on Dishman Carbogen Amcis Ltd. Business

        Dishman Carbogen Amcis Limited is a fully integrated CRAMS player with global presence offering end-to-end services in process research, development, and manufacturing of Active Pharmaceutical Ingredients.

        Dishman Carbogen Amc major competitors are Zenotech Labs., Jeevan Scientific, Vivo Bio Tech, Sun Pharma Adv. Res, Syngene Internatl., Hikal, Suven Life Sciences.
        Market Cap of Dishman Carbogen Amc is ₹2,726 Crs.
        While the median market cap of its peers are ₹3,038 Crs.

        Dishman Carbogen Amc seems to be less financially stable compared to its competitors.
        Altman Z score of Dishman Carbogen Amc is 1.41 and is ranked 7 out of its 8 competitors.

        Company Filing

        Discussions & Analysis

        Ideas Dashboard
        Results
        Timeline
        Watchlist
        Portfolio
        Alerts
        Stock Screener
        Market
        Raw Material